CCL2 and atherosclerosis: Current evidence suggests that the inflammatory pathways involved in atherosclerosis modify peripheral blood levels of molecules derived from oxidative stress and vascular inflammation markers like CRP (31, 32), IL-6, membrane and soluble ICAM1 (ICAM1s) and MCP1 (30, 31).